|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:IGL-MEF2C (FusionGDB2 ID:39231) |
Fusion Gene Summary for IGL-MEF2C |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: IGL-MEF2C | Fusion gene ID: 39231 | Hgene | Tgene | Gene symbol | IGL | MEF2C | Gene ID | 100423062 | 4208 |
| Gene name | immunoglobulin lambda like polypeptide 5 | myocyte enhancer factor 2C | |
| Synonyms | IGL|IGLV|VL-MAR | C5DELq14.3|DEL5q14.3 | |
| Cytomap | 22q11.22 | 5q14.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | immunoglobulin lambda-like polypeptide 5G lambda-1anti HBs antibody light-chain Fab fragmentgermline immunoglobulin lambda 1immunoglobin anti-granzymeB light chain variable regionimmunoglobulin lambda 1 light chainimmunoglobulin lambda 2 light chain | myocyte-specific enhancer factor 2CMADS box transcription enhancer factor 2, polypeptide C | |
| Modification date | 20200313 | 20200329 | |
| UniProtAcc | . | Q06413 | |
| Ensembl transtripts involved in fusion gene | |||